
Deccan Health Care Ltd Stock Falls to 52-Week Low of Rs.12.91
2026-03-05 10:20:54Deccan Health Care Ltd’s share price declined to a fresh 52-week low of Rs.12.91 on 5 Mar 2026, marking a significant milestone in the stock’s recent performance. This new low reflects ongoing pressures on the company’s valuation amid a challenging market environment and persistent underperformance relative to benchmarks.
Read full news article
Deccan Health Care Ltd Hits All-Time Low Amid Prolonged Underperformance
2026-03-05 09:42:10Deccan Health Care Ltd’s stock plunged to a new all-time low of Rs.12.91 on 5 Mar 2026, marking a significant milestone in its ongoing decline. The healthcare services company has experienced sustained underperformance relative to the broader market and its sector peers, reflecting persistent challenges in its financial metrics and valuation.
Read full news article
Deccan Health Care Ltd Falls to 52-Week Low of Rs.12.95 Amid Continued Underperformance
2026-03-04 18:03:19Deccan Health Care Ltd’s share price declined to a fresh 52-week low of Rs.12.95 on 4 March 2026, marking a significant downturn amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.
Read full news article
Deccan Health Care Ltd Stock Hits All-Time Low Amid Prolonged Downtrend
2026-03-04 13:02:30Deccan Health Care Ltd has reached an all-time low, closing just 1.89% above its 52-week low of ₹13, reflecting a sustained period of decline amid challenging market conditions. The stock’s recent performance continues to trail broader indices and sector benchmarks, underscoring persistent difficulties within the healthcare services company.
Read full news article
Deccan Health Care Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
2026-02-24 08:32:10Deccan Health Care Ltd has been downgraded from a Sell to a Strong Sell rating as of 23 February 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the stock continues to underperform its benchmark indices and peers, prompting a reassessment of its investment appeal across quality, valuation, financial trend, and technical parameters.
Read full news article
Deccan Health Care Ltd Upgraded to Sell on Technical Improvements Despite Long-Term Challenges
2026-02-17 08:54:22Deccan Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 16 Feb 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The healthcare services company’s recent quarterly financial performance and valuation metrics offer a mixed picture, with technical trends showing signs of improvement while long-term returns and quality scores remain subdued.
Read full news articleWhen is the next results date for Deccan Health Care Ltd?
2026-02-11 23:17:05The next results date for Deccan Health Care Ltd is scheduled for 13 February 2026....
Read full news article
Deccan Health Care Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
2026-02-06 08:17:31Deccan Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 February 2026, driven primarily by a shift in technical indicators. Despite this improvement, the healthcare services company continues to face challenges in its fundamental and financial metrics, reflecting a complex investment outlook.
Read full news article
Deccan Health Care Ltd Hits All-Time Low Amid Continued Market Underperformance
2026-01-21 09:48:01Deccan Health Care Ltd’s stock price has plunged to a new all-time low of Rs.13, marking a significant milestone in its ongoing decline. The healthcare services company has experienced sustained underperformance relative to the broader market and its sector peers, reflecting persistent pressures on its financial metrics and market valuation.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Feb-2026 | Source : BSENews Paper Publication for Unaudited Financial Results for Quarter ended December 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release
13-Feb-2026 | Source : BSEPress Release of financial results for the quarter ended 31.12.2025
Board Meeting Outcome for Considered And Approved Standalone And Consolidated Financial Results For Quarter Ended 31.12.2025
13-Feb-2026 | Source : BSEConsidered and Approved standalone and consolidated financial results for quarter ended 31.12.2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






